Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Complement System01:27

Complement System

12.7K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
12.7K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

17.4K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
17.4K
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

18.4K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
18.4K
Antibody Actions01:26

Antibody Actions

3.9K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
3.9K
Humoral Immune Responses01:36

Humoral Immune Responses

86.3K
Overview
86.3K
Sympathetic Activation01:16

Sympathetic Activation

8.4K
The sympathetic division can influence tissues and organs by releasing norepinephrine at peripheral synapses and distributing epinephrine and norepinephrine through the bloodstream. In times of crisis or stress, sympathetic activation occurs, which is regulated by sympathetic centers in the hypothalamus. As a result, sympathetic activation prepares the body for physical exertion, rapid ATP production, and heightened alertness, allowing individuals to respond effectively to challenging or...
8.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antithrombotic coating with sheltered positive charges prevents contact activation by controlling factor XII-biointerface binding.

Nature materials·2024
Same author

Survivin Promotes Stem Cell Competence for Skin Cancer Initiation.

Cancer discovery·2024
Same author

The Role of the N-Terminal Domain of Thrombomodulin and the Potential of Recombinant Human Thrombomodulin as a Therapeutic Intervention for Shiga Toxin-Induced Hemolytic-Uremic Syndrome.

Toxins·2024
Same author

Chondrocyte Thrombomodulin Protects against Osteoarthritis.

International journal of molecular sciences·2023
Same author

Smart thrombosis inhibitors without bleeding side effects via charge tunable ligand design.

Nature communications·2023
Same author

Persistently elevated complement alternative pathway biomarkers in COVID-19 correlate with hypoxemia and predict in-hospital mortality.

Medical microbiology and immunology·2022
Same journal

Phosphorylated DEK sustains leukemia stem cells by enabling PBX3-driven transcriptional reprogramming.

Blood·2026
Same journal

A single-cell atlas identifies oncogenic transcriptional programs and immune escape mechanisms in CTCL.

Blood·2026
Same journal

TRANSFORM-1 Phase 3 study: Efficacy and safety of navitoclax plus ruxolitinib in patients with untreated myelofibrosis.

Blood·2026
Same journal

Antiphospholipid syndrome (APS) is a platelet factor 4 (PF4)-centric immunothrombotic disorder.

Blood·2026
Same journal

CD4+CD25+FOXP3+ Regulatory T Cells to Protect Against Graft Versus Host Disease.

Blood·2026
Same journal

Arterial iron regulates vasodilation during anemia via endothelial holo α-globin.

Blood·2026
See all related articles

Related Experiment Video

Updated: Apr 3, 2026

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
06:29

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Published on: January 29, 2014

31.4K

HUS and the case for complement.

Edward M Conway1

  • 1Centre for Blood Research, Life Sciences Institute, Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.

Blood
|September 24, 2015
PubMed
Summary
This summary is machine-generated.

Shiga toxin-induced hemolytic-uremic syndrome (STEC-HUS) involves complement activation. New research highlights how E. coli toxins and polyphosphate influence complement and coagulation, impacting STEC-HUS progression and treatment.

More Related Videos

Depletion of Specific Cell Populations by Complement Depletion
06:17

Depletion of Specific Cell Populations by Complement Depletion

Published on: February 5, 2010

22.8K
Measuring the 50% Haemolytic Complement CH50 Activity of Serum
08:26

Measuring the 50% Haemolytic Complement CH50 Activity of Serum

Published on: March 29, 2010

39.2K

Related Experiment Videos

Last Updated: Apr 3, 2026

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
06:29

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Published on: January 29, 2014

31.4K
Depletion of Specific Cell Populations by Complement Depletion
06:17

Depletion of Specific Cell Populations by Complement Depletion

Published on: February 5, 2010

22.8K
Measuring the 50% Haemolytic Complement CH50 Activity of Serum
08:26

Measuring the 50% Haemolytic Complement CH50 Activity of Serum

Published on: March 29, 2010

39.2K

Area of Science:

  • Microbiology
  • Immunology
  • Nephrology

Background:

  • Hemolytic-uremic syndrome (HUS) is a serious condition involving microangiopathic hemolytic anemia, low platelets, and kidney failure.
  • Both atypical HUS and Shiga toxin-induced HUS (STEC-HUS) are linked to excessive complement system activation.
  • Understanding the triggers and mechanisms of STEC-HUS is crucial for effective treatment.

Purpose of the Study:

  • To review recent findings on the role of Escherichia coli-derived toxins in STEC-HUS.
  • To explore the impact of polyphosphate in modulating complement and coagulation pathways during STEC-HUS.
  • To discuss how these new insights can inform current and future therapeutic strategies for STEC-HUS.

Main Methods:

  • Literature review of recent studies on STEC-HUS pathogenesis.
  • Analysis of the mechanisms by which E. coli toxins and polyphosphate interact with complement and coagulation systems.
  • Synthesis of information regarding disease progression and treatment responses.

Main Results:

  • Escherichia coli-derived toxins play a significant role in initiating and exacerbating STEC-HUS.
  • Polyphosphate emerges as a key modulator of complement activation and coagulation in STEC-HUS.
  • These factors influence the severity of the disease and patient response to therapies.

Conclusions:

  • New knowledge on E. coli toxins and polyphosphate provides critical insights into STEC-HUS.
  • Understanding these molecular mechanisms can guide the development of targeted therapies for STEC-HUS.
  • Future treatment choices for STEC-HUS may be significantly impacted by these advancements.